Endoscopic removal of an embedded partially covered esophageal self-expandable metallic stent by overtube technique

Yan, Sheng-Lei; Chen, C. H.; Yeh, Yung‐Hsiang; Yueh, Shing-Kao

doi:10.1055/s-0030-1256945

Cited by 8 publications

(4 citation statements)

References 4 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Although this can reduce the dwell time of the stent and make removal more difficult, novel methods of removing these stents after mucosal embedment may still allow prolonged placement without significant complications during their removal. 14,15 Lastly, the use of intralesional steroid injection with stent removal may prevent or prolong time to recurrence of strictures, similar to our experience with serial endoscopic dilations. However, this has not been well described and deserves further investigation.…”

Section: Discussionsupporting

confidence: 57%

“…Partially covered stents may also reduce the frequency of migration by allowing some degree of epithelialization and stent embedment into the esophageal wall. Although this can reduce the dwell time of the stent and make removal more difficult, novel methods of removing these stents after mucosal embedment may still allow prolonged placement without significant complications during their removal . Lastly, the use of intralesional steroid injection with stent removal may prevent or prolong time to recurrence of strictures, similar to our experience with serial endoscopic dilations.…”

Section: Discussionmentioning

confidence: 72%

See 1 more Smart Citation

Removable esophageal stents have poor efficacy for the treatment of refractory benign esophageal strictures (RBES)

et al. 2012

View full text Add to dashboard Cite

With the recent availability of removable esophageal stents, endoscopic stenting has been utilized to treat refractory benign esophageal strictures (RBES). The objective of this study was to review the feasibility and effectiveness of removable esophageal stents to treat RBES. Patients who received removable esophageal stents for the treatment of RBES at the institution between 2004-2010 using its stent implantation logs and endoscopic database were retrospectively identified. Patient demographics, stricture etiology and location, stent and procedure characteristics, and clinical outcomes were obtained. Twenty-five patients with a mean age of 70 (72% male) underwent initial stent placement; 24 were successful. Overall clinical success was achieved in five of the 19 patients (26%) ultimately undergoing stent removal. RBES etiologies included anastomotic (13), radiation (5), peptic (3), chemotherapy (1), scleroderma (1), and unknown (2). Alimaxx-E (Merit-Endotek, South Jordan, UT, USA) stents were placed in 20 patients and Polyflex (Boston Scientific, Natick, MA, USA) stents were used in five patients. Immediate complications included failed deployment (1) and chest pain (7). Five patients died prior to stent removal. Stent migration was found in 53% (10/19) of patients who underwent stent removal: nine required additional therapy and one had symptom resolution. Out of the nine patients without stent migration, five required additional therapy and four had symptom resolution. Although placement of removable esophageal stents for RBES is technically feasible, it is frequently complicated by stent migration and chest pain. In addition, few patients achieved long-term stricture resolution after initial stenting. In this study, most patients ultimately required repeated stenting and/or dilations to maintain relief of dysphagia.

show abstract

Section: Discussionsupporting

confidence: 57%

Section: Discussionmentioning

confidence: 72%

Removable esophageal stents have poor efficacy for the treatment of refractory benign esophageal strictures (RBES)

et al. 2012

View full text Add to dashboard Cite

show abstract

“…[18][19][20][21][22][23][24] Short-and long-term data regarding techniques for removal of embedded stents are extremely limited. The OT procedure effectively dislodges the stent in a single procedure, although it potentially increases the risk of bleeding, perforation, and esophageal avulsion.…”

mentioning

confidence: 99%

Stent-in-stent technique for removal of embedded partially covered self-expanding metal stents

et al. 2015

View full text Add to dashboard Cite

show abstract

“…Owing to prominent tissue ingrowth at both uncovered ends of the SEMS after 5 weeks later, and difficulty for removal. We applied overtube to help to remove SEMS [9]. Several days later, a fistula developed then we injected histoacryl to seal the hole.…”

Section: Surgical Techniquementioning

confidence: 99%

Endoscopic Management of Leaks Following Laparoscopic Sleeve Gastrectomy: The Experience of IRCAD Taiwan

Lin¹,

Ou²,

Lee³

et al. 2020

View full text Add to dashboard Cite

Endoscopic removal of an embedded partially covered esophageal self-expandable metallic stent by overtube technique

Cited by 8 publications

References 4 publications

Removable esophageal stents have poor efficacy for the treatment of refractory benign esophageal strictures (RBES)

Removable esophageal stents have poor efficacy for the treatment of refractory benign esophageal strictures (RBES)

Stent-in-stent technique for removal of embedded partially covered self-expanding metal stents

Endoscopic Management of Leaks Following Laparoscopic Sleeve Gastrectomy: The Experience of IRCAD Taiwan

Contact Info

Product

Resources

About